A break-even price calculation for the use of sirolimus-eluting stents in angioplasty
- 1 March 2003
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (3) , 1007-1016
- https://doi.org/10.1016/s0149-2918(03)80121-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Intracoronary stenting: developments since the NICE reportHeart, 2002
- Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registryInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Use of localised intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trialThe Lancet, 2002
- Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarctionHeart, 2001
- Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary ArteriesCirculation, 2001
- Evaluation of the cost-effectiveness of coronary stenting: A societal perspectiveAmerican Heart Journal, 1999
- Acute and long-term cost implications of coronary stentingJournal of the American College of Cardiology, 1999
- Coronary-Artery Stents — Gauging, Gorging, and GougingNew England Journal of Medicine, 1998
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994